Venture Capital Archives - Page 2 of 111 - Boston Life Sciences Times

NEJM Publishes Data Suggesting Zorevunersen May Modify Disease Course in Dravet Syndrome

March 5, 2026

Arsenal Medical Treats First Patient with ResQFoam Device for Life-Threatening Abdominal Bleeding

March 4, 2026

Konovo Appoints Jessica Santos as Chief Compliance and Privacy Officer

March 3, 2026

THIS WEEK'S STORIES

KalVista Highlights Patient Satisfaction, Early Treatment Benefits for EKTERLY at Major Allergy Meetings

March 2, 2026

Affinia Therapeutics Receives FDA Fast Track Designation for AFTX-201 Gene Therapy for BAG3-Associated Dilated Cardiomyopathy

March 4, 2026

Amylyx Pharmaceuticals Narrows Losses in 2025 as Phase 3 Avexitide Trial Nears Completion

March 3, 2026

ABOUT US

Life Science Times is New England’s premier life sciences publication, covering the Pharma, Biotech, MedTech and Public Health sectors nationwide with a special focus on New England. Updated daily, we cover the latest news in everything else that touches any rubric of the rapidly growing life sciences industry.

Venture Capital

Cambridge Startup Axiomatic AI Raises $18M to Build Verified AI Platform for Engineering

Cognito Therapeutics Raises $105 Million Series C to Advance Alzheimer’s Therapy Platform

Poplar Therapeutics Raises $45 Million to Advance Anti-IgE Therapy for Food Allergy and Atopic Diseases

BreezeBio Raises $60 Million in Series B to Advance Precision Genetic Medicines Pipeline

Synthpop Raises $15 Million Series A to Expand AI Platform for Healthcare Workflow Automation

Most Read

Newton Women’s Health Company Reports Study Showing Leva Device Improves Fecal Incontinence Symptoms

Study Suggests Daily Multivitamin May Slow Biological Aging

FDA Grants Priority Review to ENHERTU for High-Risk HER2-Positive Early Breast Cancer

UK Biotech Firm Abselion Opens U.S. Subsidiary in Cambridge Innovation Hub

EDITOR PICKS